Pelthos Therapeutics PTHS
NYSE PTHS
$21.35 +0.43 (+2.08%)
As of: Sep 30, 2026 · 10:00 AM EDT

Pelthos Therapeutics (PTHS) EBITDA (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded EBITDA of -$16 million in Q2 2026, compared with -$3.23 million a year earlier.

Analysis

Pelthos Therapeutics (PTHS) EBITDA (2025 - 2026) Analysis & Trends

On a TTM basis, Pelthos Therapeutics' EBITDA came in at -$52.67 million as of Jun 30, 2026; for FY2025, it came in at -$30.15 million.

  • Across earlier years, EBITDA came in at -$7.57 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$11.59 million (Q1 2026), -$10.47 million (Q4 2025) and -$14.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Pelthos Therapeutics 81.21 Mn -7.18 Mn 11.99 Mn -16.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.00 Mn
Mar 31, 2026 -11.59 Mn
Dec 31, 2025 -10.47 Mn
Sep 30, 2025 -14.61 Mn
Jun 30, 2025 -3.23 Mn
Mar 31, 2025 -1.83 Mn
API Access

Pelthos Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=PTHS&period=max&api_key=YOUR_API_KEY